Intuitive Surgical, Inc. (ISRG)

ISRG Expands SP Indications: A Game Changer in Colorectal Surgery?

Intuitive Surgical's SP platform secures new colorectal clearances, with 88% growth in procedures and rising global adoption momentum.

Is Intuitive Surgical the Hidden Winner in Healthcare's Weakness?

The medical sector in the United States has been heavily affected by a bearish cycle, driven by scandals surrounding the GLP-1 drugs used in weight loss solutions for consumers. As more companies are exposed to the manufacturing and distribution of these drugs, even some unrelated names have been dragged down by this broader sentiment, creating massive opportunities for those who are bold enough to look into the space.

ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?

The robotic surgery market is undergoing rapid transformation, driven by technological advancements, increasing adoption in hospitals, and a shift toward minimally invasive procedures. As of 2025, it's growing rapidly, focusing on precision, AI integration, and expanding its use across specialties like urology, gynecology, orthopedics, and general surgery.

Is Most-Watched Stock Intuitive Surgical, Inc. (ISRG) Worth Betting on Now?

Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

ISRG SP Platform's Expansion in Korea and Europe Gains Traction

Intuitive Surgical's SP platform gains momentum with 112% growth in Korea and steady European uptake, highlighting global adoption despite regional headwinds.

Intuitive Surgical Stock Is Trading Near Its 52-Week Low. Could This Be a No-Brainer Buy for the Long Haul?

Intuitive Surgical (ISRG 0.19%) makes surgical systems that are transforming the healthcare industry, making it easier for surgeons to conduct difficult surgeries. And that can increase success rates in surgery and improve outcomes from patients.

ISRG Stock Dips Despite Introducing Real-Time Insights on da Vinci 5

Intuitive Surgical unveils real-time surgical insights on its da Vinci 5, enhancing precision, safety, and efficiency with advanced software features.

ISRG Stock Down More than 13% in 3 Months: How to Play the Stock?

Intuitive Surgical shares are down 13% in three months as margin pressures weigh on the stock, but strong procedure growth keeps its long-term story intact.

Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know

Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Intuitive Introduces Real-Time Surgical Insights for da Vinci 5

SUNNYVALE, Calif., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the first in a series of new software capabilities for da Vinci 5, designed to enhance surgeon and hospital efficiency through the delivery of a range of real-time surgical insights.

Wall Street Bulls Look Optimistic About Intuitive Surgical (ISRG): Should You Buy?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Ion Platform Poised for Cost Optimization: A Margin Lever for ISRG?

Intuitive Surgical's Ion platform is driving rapid growth, but cost optimization could be the key to turning it from a margin drag to a margin lever.

MemorialCare Launches Da Vinci 5 Robotic Surgical System, Expanding Robotic Surgical Program Access Across All Hospitals in Health System

Next-generation technology enhances precision, improves patient outcomes, and expands minimally invasive surgery across Long Beach, Fountain Valley and Laguna Hills. FOUNTAIN VALLEY, Calif.

Intuitive Surgical: What's Happening With ISRG Stock?

Intuitive Surgical stock (NASDAQ: ISRG) has dropped 16% this year, notably lagging behind the S&P 500's 10% increase. The stock has experienced downward pressure recently after management indicated that potential tariffs may adversely affect its performance in 2026.

Intuitive Surgical, Inc. (ISRG) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Intuitive Surgical, Inc. (NASDAQ:ISRG ) Wells Fargo 20th Annual Healthcare Conference 2025 September 3, 2025 9:30 AM EDT Company Participants David Rosa - CEO & Director Jamie Samath - CFO, Head of Business Technology & Enterprise Technology Leader Conference Call Participants Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Presentation Larry Biegelsen Senior Medical Device Equity Research Analyst All right. Good morning, everyone.

The Best Home Run Growth Stocks To Buy Today

ISRG's SP Stapler: A Game Changer for Colorectal and Thoracic Procedures?

Intuitive Surgical's new SP stapler opens doors to colorectal and thoracic surgeries, potentially transforming the single-port platform's adoption curve.

Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It

Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

ISRG vs. MDT: Which MedTech Titan Is the Stronger Investment Choice Now?

ISRG's strong double-digit robotic growth stands in contrast to MDT's diversified portfolio and more attractive valuation, setting up a compelling medtech comparison.

SP Platform's 88% Procedure Growth: The Next Frontier for ISRG?

Intuitive Surgical's SP platform posts 88% procedure growth in Q2, driven by a 112% surge in Korea and expanding adoption in colorectal and thoracic surgery.

Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Good Investment: Is It?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

ISRG's International Push for Ion: Strategic Bet or Overstretch?

Intuitive Surgical expands Ion into Australia and Korea after 52% procedure growth, testing Asia-Pacific adoption despite budget headwinds.

ISRG's Ion Platform Procedure Grows 52%: Can This Trend Continue?

Intuitive Surgical's Ion platform saw Q2 procedures jump 52% to 35,000, expanding globally as utilization rises despite softer system placements.

ISRG's Post-Earnings Slide: Margin Worries Overshadow Growth Story

Intuitive Surgical's Q2 revenues and procedure gains look good, but tariffs, cost inflation, and margin pressure spur a post-earnings selloff.

Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock

Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Cathie Wood Goes Shopping: 3 Stocks She Just Bought

Cathie Wood is built for rallying markets. The co-founder, CEO, and chief investment officer of Ark Invest is crushing the market this year, proving that she can catch 2020 in a bottle again.

Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

ISRG's Gross Margin Falls on Product Transition and Trade Pressures

Intuitive Surgical's Q2 gross margin declines to 67.9% as product mix shifts, new facility costs and tariffs weigh on profitability.

Can ISRG's Strong Q2 Procedure Volume Translate Into Durable EPS Upside?

ISRG's Q2 procedure growth hits 17%, but continuation of EPS growth hinges on easing margin pressure from FX and da Vinci 5 adoption.